March
7
TriSalus Life Sciences Receives Approval from the World Health Organization and the American Medical Association’s Adopted Name Council for “Nelitolimod” as the Nonproprietary Drug Name for SD-101
– Nelitolimod, a class C TLR-9 agonist formerly called SD-101, is the Company’s therapeutic candidate...